Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kiyoshi Kitano

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
International Journal of Hematology|July 4, 2012
Clinical characteristics of human immunodeficiency virus-associated Hodgkin lymphoma patients in JapanMihoko Yotsumoto, Shotaro Hagiwara, Atsushi Ajisawa, et al.
International Journal of Hematology|December 18, 2012
Prognosis of mature T cell lymphoma is poorer than that of diffuse large B cell lymphoma in IPI low-risk group, but not in intermediate- and high-risk groupsRika Kihara, Tomoyuki Watanabe, Takahiro Yano, et al.
Leukemia & Lymphoma|May 17, 2017
Phase II study of intensified rituximab induction and maintenance for low grade B cell lymphomaHirokazu Nagai, Takeshi Shimomura, Makoto Takeuchi, et al.
International Journal of Hematology|March 30, 2018
Bortezomib maintenance therapy in transplant-ineligible myeloma patients who plateaued after bortezomib-based induction therapy: a multicenter phase II clinical trialAtsushi Isoda, Kayoko Murayama, Shigeki Ito, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
International Journal of Hematology|July 4, 2012
Clinical characteristics of human immunodeficiency virus-associated Hodgkin lymphoma patients in JapanMihoko Yotsumoto, Shotaro Hagiwara, Atsushi Ajisawa, et al.
International Journal of Hematology|December 18, 2012
Prognosis of mature T cell lymphoma is poorer than that of diffuse large B cell lymphoma in IPI low-risk group, but not in intermediate- and high-risk groupsRika Kihara, Tomoyuki Watanabe, Takahiro Yano, et al.
Leukemia & Lymphoma|May 17, 2017
Phase II study of intensified rituximab induction and maintenance for low grade B cell lymphomaHirokazu Nagai, Takeshi Shimomura, Makoto Takeuchi, et al.
International Journal of Hematology|March 30, 2018
Bortezomib maintenance therapy in transplant-ineligible myeloma patients who plateaued after bortezomib-based induction therapy: a multicenter phase II clinical trialAtsushi Isoda, Kayoko Murayama, Shigeki Ito, et al.
Pageof 3